# Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases

> **NCT04461418** · PHASE2 · TERMINATED · sponsor: **AHS Cancer Control Alberta** · enrollment: 2 (actual)

## Conditions studied

- Brain Metastases, Adult

## Interventions

- **DRUG:** Glucocorticoid therapy

## Key facts

- **NCT ID:** NCT04461418
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-03-30
- **Primary completion:** 2023-09-23
- **Final completion:** 2023-09-23
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Lack of Accrual
- **Last updated:** 2025-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04461418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04461418, "Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04461418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*